Evidence map›Paper›PMID 29882359›Full record

ArticleStatistics in medicine2018

Exploring causality mechanism in the joint analysis of longitudinal and survival data.

Lei Liu, Cheng Zheng, Joseph Kang

Abstract read
In one paragraph

Article in Statistics in medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Robust evaluation of longitudinal surrogate markers with censored data.Journal of the Royal Statistical Society. Series B, Statistical methodology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lei LiuDivision of Biostatistics, Washington University in St. Louis, St. Louis, MO, USA.ORCID 0000-0003-1844-338X
Cheng ZhengJoseph J. Zilber School of Public Health, University of Wisconsin-Milwaukee, Milwaukee, WI, USA.ORCID 0000-0002-6562-870X
Joseph KangCenters for Disease Control and Prevention, Atlanta, GA, USA.ORCID 0000-0002-3257-5904

Funding

Innovative methods for modeling longitudianl medical costsR01HS020263 · AHRQ · UNIVERSITY OF VIRGINIA · PI LIU, LEI · 2011 to 2015
$2.0M
Methods to Improve Personalized Cardiovascular Disease Prevention Across the Life CourseR01HL136942 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ZHAO, LIHUI · 2017 to 2020
$1.6M
AHRQ HHS R01 HS020263NHLBI NIH HHS R01 HL136942
6 · The paper itself

Abstract

In many biomedical studies, disease progress is monitored by a biomarker over time, eg, repeated measures of CD4 in AIDS and hemoglobin in end-stage renal disease patients. The endpoint of interest, eg, death or diagnosis of a specific disease, is correlated with the longitudinal biomarker. In this paper, we examine and compare different models of longitudinal and survival data to investigate causal mechanisms, specifically, those related to the role of random effects. We illustrate the methods by data from two clinical trials: an AIDS study and a liver cirrhosis study.

Indexed as

CausalityLongitudinal StudiesSurvival AnalysisAlgorithmsBiomarkersCD4 AntigensHIV InfectionsKidney Failure, ChronicModels, StatisticalProthrombinBiomarkersCD4 AntigensProthrombininteractionmediation analysismoderatorrepeated measuresshared random effects

Identifiers

PMID29882359
PMCPMC6535086

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.